azoxymethane has been researched along with nutlin-3a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aizu, W; Belinsky, GS; Boes, CC; Doshi, B; Flynn, C; Giardina, C; Godman, CA; Nambiar, PR; Noonan, EJ; Rosenberg, DW | 1 |
| Belinsky, GS; Giardina, C; Rigatti, MJ; Rosenberg, DW; Verma, R | 1 |
2 other study(ies) available for azoxymethane and nutlin-3a
| Article | Year |
|---|---|
Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors.
Topics: Animals; Apoptosis; Azoxymethane; Carcinogens; Cell Line, Tumor; Colonic Neoplasms; Genes, p53; Imidazoles; Male; Mice; Mice, Inbred Strains; Piperazines; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53 | 2006 |
Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azoxymethane; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; DNA Damage; Doxorubicin; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Imidazoles; Mice; Neoplasms, Experimental; Piperazines; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53 | 2012 |